US Broker Ratings

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a 307.96% Potential Upside in the Biotech Sector

Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector due to its promising pipeline of gene and cell therapies..

Alumis Inc. (ALMS) Investor Outlook: Biotech Innovator with a 45% Upside Potential

Alumis Inc. (NASDAQ: ALMS), a burgeoning force in the biotechnology sector, is drawing significant attention from investors with its promising pipeline of treatments for autoimmune disorders...

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring a Bold 67% Upside Potential

Investors with an eye on the biotechnology sector might find Entrada Therapeutics, Inc. (NASDAQ: TRDA) an intriguing prospect, with a potential upside of 67.12% based on..

Zhengye Biotechnology (ZYBT) Stock Analysis: Can This Chinese Vaccine Maker Rebound from a 52-Week Low?

Investors eyeing opportunities in the healthcare sector may want to take a closer look at Zhengye Biotechnology Holding L (ZYBT), a Chinese company focused on the..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Unpacking a Potential 94.89% Upside in the Biotech Sector

For investors with an eye on the biotechnology sector, Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) presents a compelling opportunity, driven by its substantial potential upside of 94.89%...

Quantum-Si Incorporated (QSI) Investor Outlook: Exploring a Potential 158% Upside

Quantum-Si Incorporated (NASDAQ: QSI) is making waves in the healthcare sector, particularly in the medical devices industry, with its innovative approach to protein sequencing technology. As..

Canopy Growth Corporation (CGC): Investor Outlook Reveals 69% Potential Upside

Canopy Growth Corporation (NASDAQ: CGC), headquartered in Smiths Falls, Canada, continues to be a focal point for investors eyeing the burgeoning cannabis industry. As a major..

Candel Therapeutics (CADL) Stock Analysis: A Biotech with a 236% Upside Potential

Candel Therapeutics, Inc. (NASDAQ: CADL), a pioneering entity in the biopharmaceutical landscape, is capturing investor attention with its impressive potential upside of 236.80%. This clinical-stage biotech..

Pacific Biosciences of California (PACB) Stock Analysis: Exploring the 31% Potential Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB) stands out in the healthcare sector’s medical devices industry, particularly for its innovative solutions in the field of genetic..

Exxon Mobil Corporation (XOM) Stock Analysis: Navigating a Challenging Market with Strategic Stability

Exxon Mobil Corporation (NYSE: XOM), a behemoth in the energy sector with a market capitalization of $656.02 billion, continues to be a focal point for investors..

Chevron Corporation (CVX) Investor Outlook: Navigating Growth with a 3.83% Dividend Yield

Chevron Corporation (NYSE: CVX), a titan in the global energy sector, stands tall with a market capitalization of $371.52 billion. Known for its comprehensive operations in..

Aurora Cannabis Inc. (ACB) Stock Analysis: Exploring an 86.95% Potential Upside

Aurora Cannabis Inc. (NYSE: ACB) continues to be a focal point for investors eyeing the burgeoning cannabis sector. With its diverse portfolio and international reach, Aurora..

Spok Holdings, Inc. (SPOK) Stock Analysis: Navigating a 55.67% Potential Upside Amid High Dividend Yield

Spok Holdings, Inc. (NASDAQ: SPOK), a key player in the healthcare communication solutions sector, presents a unique blend of stability and opportunity for investors seeking exposure..

Outset Medical, Inc. (OM)

⚠️ No article content returned.

..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a 326% Potential Upside in the Healthcare Sector

Alpha Teknova, Inc. (NASDAQ: TKNO) stands as a noteworthy player in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic products...

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 32% Upside Potential

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with a potential upside of..

TruBridge, Inc. (TBRG) Investor Outlook: A Glimpse Into a Potential 21.60% Upside

TruBridge, Inc. (NASDAQ: TBRG), a prominent player in the healthcare sector, operates within the health information services industry, providing critical solutions to enhance financial health and..

ClearPoint Neuro Inc. (CLPT): Investor Outlook Reveals 116.90% Potential Upside in Medical Devices Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT), a pioneering player in the healthcare sector’s medical devices industry, is capturing investor attention with its impressive potential upside of 116.90%...

Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech with 145% Upside Potential

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company based in Singapore, is capturing the attention of investors with its innovative approach to RNA medicine...

The Pennant Group, Inc. (PNTG) Stock Report: A Promising 21.75% Upside for Healthcare Investors

The Pennant Group, Inc. (NASDAQ: PNTG) is emerging as a compelling opportunity for investors within the healthcare sector. With a robust market capitalization of $1.07 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds